Literature DB >> 2440687

What is the role of angiogenesis in metastasis from cutaneous melanoma?

J Folkman.   

Abstract

Entities:  

Mesh：

Year:  1987        PMID： 2440687     DOI： 10.1016/0277-5379(87)90370-1

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN： 0277-5379


× No keyword cloud information.
  12 in total

Review 1.  Regressing thin cutaneous malignant melanomas (< or = 1.0 mm) are associated with angiogenesis.

Authors:  R L Barnhill; M A Levy
Journal:  Am J Pathol       Date:  1993-07       Impact factor: 4.307

Review 2.  A systems approach to cancer therapy. (Antioncogenics + standard cytotoxics-->mechanism(s) of interaction).

Authors:  B A Teicher
Journal:  Cancer Metastasis Rev       Date:  1996-06       Impact factor: 9.264

Review 3.  Incorporating VEGF-targeted therapy in advanced urothelial cancer.

Authors:  Sujata Narayanan; Sandy Srinivas
Journal:  Ther Adv Med Oncol       Date:  2016-09-16       Impact factor: 8.168

4.  A heparin-binding angiogenic protein--basic fibroblast growth factor--is stored within basement membrane.

Authors:  J Folkman; M Klagsbrun; J Sasse; M Wadzinski; D Ingber; I Vlodavsky
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

5.  Angiogenesis a putative new approach in glutamine related therapy.

Authors:  P Maity; S Chakraborty; P Bhattacharya
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

Review 6.  Molecular pathways in bladder cancer.

Authors:  Stephen G Williams; John P Stein
Journal:  Urol Res       Date:  2004-11-13

7.  Various cell types in human atherosclerotic lesions express ICAM-1. Further immunocytochemical and immunochemical studies employing monoclonal antibody 10F3.

Authors:  M M Peclo; A M Gown
Journal:  Am J Pathol       Date:  1992-04       Impact factor: 4.307

8.  beta-cyclodextrin tetradecasulfate/tetrahydrocortisol +/- minocycline as modulators of cancer therapies in vitro and in vivo against primary and metastatic Lewis lung carcinoma.

Authors:  B A Teicher; E A Sotomayor; Z D Huang; G Ara; S Holden; V Khandekar; Y N Chen
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

9.  Potentiation of cytotoxic therapies by TNP-470 and minocycline in mice bearing EMT-6 mammary carcinoma.

Authors:  B A Teicher; S A Holden; N P Dupuis; Y Kakeji; M Ikebe; Y Emi; D Goff
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

10.  Minocycline in combination with chemotherapy or radiation therapy in vitro and in vivo.

Authors:  E A Sotomayor; B A Teicher; G N Schwartz; S A Holden; K Menon; T S Herman; E Frei
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.